Home › General News › Article

ASEAN City helps Leye's Chinese medicinal herb industry move toward a 100-billion-yuan output value

General News 0 views
"ASEAN City" seeks to unlock Leye's Chinese medicinal herb industry with a 100-billion-yuan output value

    Nowadays, traditional Chinese medicine healthcare and treatment are heating up once again and are strongly favored by the medical industry. However, because parts of our country's environment have been polluted and the climate has also undergone some changes, the composition and content of cultivated medicinal herbs have directly changed, the medicinal effects are greatly reduced, and as a direct result the therapeutic efficacy cannot be guaranteed, bringing serious trouble to traditional Chinese medicine healthcare and treatment.

    To this end, Zhou Houlin, dean of the ASEAN Academy of Traditional Chinese Medicine Sciences, an expert in traditional Chinese medicine, and a health physician honored for contributions to the "Two Bombs, One Satellite" program, traveled from his rural hometown of Yulin, the medicine capital of the South, to Leye County in Baise, Guangxi - the world's hometown of longevity, the kingdom of rich vitamin C, and a national organic agriculture demonstration base - and established a seedling research and nursery base, an imitation wild cultivation Chinese herbal medicine base, and Guangxi Leye Tiankeng Medicine Capital Organic Chinese Medicinal Materials Technology Co., Ltd., with "ASEAN City" as its flagship brand. Over 4 years, he planted more than 30,000 mu of Chinese medicinal herbs in Leye County, Guangxi, and plans to reach a planting area of more than 200,000 mu within 3-5 years, exporting to the world nearly 100 kinds of high-quality, organic Chinese medicinal herbs and fruits that are independently researched and developed, cultivated, and grafted, including honeysuckle, polygonatum odoratum, polygonatum sibiricum, pseudostellaria heterophylla, atractylodes macrocephala, Baphicacanthus cusia, mahonia fortunei, leonurus, Rosa roxburghii, Millettia speciosa, Ophiopogon japonicus, Eucommia ulmoides, Tetrapanax papyrifer, Stephania, agarwood, nectarine, Polygonum multiflorum, Lysimachia christinae, lily, walnut, and red-fleshed kiwifruit.

    Zhou Houlin, chairman of Guangxi Leye Tiankeng Medicine Capital Organic Chinese Medicinal Materials Technology Co., Ltd., stated that he has now put down roots in Leye and will devote himself single-mindedly to building Leye into a Chinese medicinal herb industry with an output value of over 100 billion yuan, leading local farmers to prosper together and achieve true poverty alleviation and prosperity.

Zhou Houlin, chairman of Guangxi Leye Tiankeng Medicine Capital Organic Chinese Medicinal Materials Technology Co., Ltd.

    The rise of Leye's Chinese medicinal herb industry with a 100-billion-yuan output value

    In recent years, "foreign Chinese medicine" has been quite popular in the domestic market. After China's Chinese medicinal materials are exported abroad, they are deeply processed into "kampo preparations" and then sold back to the Chinese market. Although the price is several times that of similar domestic products, it still cannot stop people's enthusiasm for buying. For example, German companies purchase Chinese rough-processed ginkgo leaves at a price of a few yuan per jin, and after deep processing research and development, produce cholesterol-lowering drugs priced as high as several hundred yuan. China's ancient formula "Liu Shen Wan" was modified and developed by Japan into "Kyushin Dan," creating a sales miracle of more than 100 million US dollars per year. The above phenomena reflect a severe lack of innovation capacity in China's Chinese herbal extraction technology. Demand for new drugs made from Chinese herbal extracts is strong, and enormous business opportunities lie hidden in China's Chinese herbal medicine industry.

    Zhou Houlin is a child from the mountains and has been full of love for the mountains since childhood. After graduating from Guangxi University of Chinese Medicine with a major in traditional Chinese medicine, he worked and studied at many medical colleges, research institutes, community outpatient departments, and clinics, and is the inheritor of the traditional Chinese medicine academic lineage of Professor Huang Ronghuo, a nationally famous veteran traditional Chinese medicine doctor. He has made achievements in the medical field and continuously explores the cultivation, planting, grafting, extraction, and use of new medicinal materials. At present, in addition to having a seedling research and nursery base and an imitation wild cultivation Chinese herbal medicine base in Leye, he has also set up the ASEAN City Traditional Chinese Medicine Research Institute laboratory and the Guangxi ASEAN City Traditional Chinese Medicine Research Institute processing plant in Nanning, Guangxi. He has never stopped research in Chinese herbal medicine and medicine, and has a particularly special affection for Chinese herbal medicine.

    As for the 200,000-mu planting base planned by Guangxi Leye Tiankeng Medicine Capital Organic Chinese Medicinal Materials Technology Co., Ltd. in Leye County, if calculated according to the annual market price of raw materials of 18,000 yuan/mu, the annual income is about 3.6 billion yuan; calculated according to the drug extraction price (8-12 times the market price of raw materials), the annual income is about 30 billion yuan; calculated according to the price of drug extracts used as raw materials (30 times the market price of raw materials), the annual income is about 108 billion yuan; calculated according to the price of deeply processed drugs and foods (50 times the market price of raw materials), the annual income exceeds 180 billion yuan. However, because the proportion of deep processing of Chinese medicinal raw materials in our country each year is still very low, the industrial value brought by the traditional industrial model of relying solely on selling Chinese herbal raw materials is limited, and the speed is also relatively slow.

    Senior experts in the medical field who are familiar with Zhou Houlin say that he is a very persistent and focused person. With the improvement of his ability to use and extract medicinal materials, in the future, driven by the 200,000-mu Chinese herbal medicine base he has planted, the development of Leye's Chinese medicinal herb industry ecological sightseeing and wellness will be accelerated.

    Innovative model works, achieving "targeted poverty alleviation"

    Zhou Houlin has an indissoluble bond with Chinese herbal medicine, and he harbors three dreams: the Chinese Dream, the Chinese medicine dream, and the poverty alleviation dream. Since he personally led a team into Baise's Leye County in 2012, he has dreamed of leading farmers to prosper together, actively guiding farmers to participate in entrepreneurship, providing farmers with good support conditions for entrepreneurship such as seed sources, technology, processing, and markets, and giving support in policies and funds, realizing the "driving of concepts, resources, technology, industry, and markets" for farmers' development. He vigorously promotes the construction of Chinese medicinal herb and kiwifruit seedling bases, and uses demonstration-driven methods to promote the formation and development of premium agriculture; and by continuously extending the industrial chain, he links together the small-scale farming production of individual households and gradually realizes integrated operation of planting, processing, and production, supply, and sales.

    At the same time, the company has also implemented the "Leye County High-Altitude Mountain Area Imitation Wild Chinese Medicinal Herb Planting Demonstration Base" project, established the Leye County Chinese Herbal Medicine Sustainable and Efficient Utilization Experimental Zone Demonstration Base, carried out multi-variety trials of Chinese herbal medicine, conducted production according to the GAP technical standards for Chinese medicinal materials, implemented full-process control of the production process, standardized each production link, prevented contamination by various toxic and harmful substances, ensured the quality of Chinese medicinal material products, and aligned with international agricultural product quality standards.

    In the construction of Chinese medicinal material GAP, a market operation mechanism is implemented, using the model of "farmer + cooperative + company + scientific research unit + sales dividends" to drive the development of the industry, allowing enterprises and farmers to establish benefit and cooperative relationships, driving enterprises to create brands, brands to connect with bases, and bases to lead farmers, achieving win-win benefits and resource sharing between enterprises and farmers, and truly realizing "targeted poverty alleviation." As of now, it has helped more than 6,000 people in Leye escape poverty and prosper.

Related Articles